115 related articles for article (PubMed ID: 32991494)
1. Cytotoxic T-Lymphocyte-Associated Protein-4 and Lymphocyte Activation Gene-3 Expression in Orbitally-Invasive Versus Nodular Basal Cell Carcinoma.
Lajoie JE; Lau KW; Adam AP; Wladis EJ
Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3S):S109-S111. PubMed ID: 32991494
[TBL] [Abstract][Full Text] [Related]
2. CD73 Is Enriched in Cutaneous Carcinomas That Invade the Orbit.
Wladis EJ; Weller B; Adam AP
Ophthalmic Plast Reconstr Surg; 2020; 36(3):247-249. PubMed ID: 31743281
[TBL] [Abstract][Full Text] [Related]
3. The immune checkpoints Cytotoxic T lymphocyte antigen-4 and Lymphocyte activation gene-3 expression is up-regulated in acute myeloid leukemia.
Radwan SM; Elleboudy NS; Nabih NA; Kamal AM
HLA; 2020 Jul; 96(1):3-12. PubMed ID: 32189430
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer.
Welsh MM; Applebaum KM; Spencer SK; Perry AE; Karagas MR; Nelson HH
Cancer Res; 2009 Aug; 69(15):6158-63. PubMed ID: 19622768
[TBL] [Abstract][Full Text] [Related]
5. Programmed Death-1 Pathway in Orbital Invasion of Cutaneous Carcinomas.
Wladis EJ; Lee JA; Carlson JA; Martino N; Adam AP
Ophthalmic Plast Reconstr Surg; 2018; 34(2):110-113. PubMed ID: 28350690
[TBL] [Abstract][Full Text] [Related]
6. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
[TBL] [Abstract][Full Text] [Related]
7. Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype.
Shokrgozar N; Karimi M; Golmoghaddam H; Rezaei N; Moayed V; Sharifzadeh S; Arandi N
Ann Hematol; 2021 Oct; 100(10):2463-2469. PubMed ID: 34324022
[TBL] [Abstract][Full Text] [Related]
8. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
Kassardjian A; Shintaku PI; Moatamed NA
PLoS One; 2018; 13(4):e0195958. PubMed ID: 29672601
[TBL] [Abstract][Full Text] [Related]
9. Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes.
Kamal AM; Wasfey EF; Elghamry WR; Sabry OM; Elghobary HA; Radwan SM
Clin Biochem; 2021 Oct; 96():13-18. PubMed ID: 34217699
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
11. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
[TBL] [Abstract][Full Text] [Related]
12. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.
Yu M; Zloty D; Cowan B; Shapiro J; Haegert A; Bell RH; Warshawski L; Carr N; McElwee KJ
J Invest Dermatol; 2008 Jul; 128(7):1797-805. PubMed ID: 18200053
[TBL] [Abstract][Full Text] [Related]
13. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.
Howell BG; Solish N; Lu C; Watanabe H; Mamelak AJ; Freed I; Wang B; Sauder DN
J Dermatol Sci; 2005 Jul; 39(1):39-51. PubMed ID: 15978418
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of TIM-3, LAG-3, IDO, PD-L1, and CTLA-4 during nimotuzumab therapy correlates with responses and prognosis of oral squamous cell carcinoma patients.
Wang H; Mao L; Zhang T; Zhang L; Wu Y; Guo W; Hu J; Ju H; Ren G
J Oral Pathol Med; 2019 Sep; 48(8):669-676. PubMed ID: 31132187
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes.
Arch Dermatol Res; ; . PubMed ID: 34647186
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
